RxDoctor Payments Data

Jesse Smith, MD

Plastic and Reconstructive Surgery · Knoxville, TNNPI 1124431275

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.8% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 39.8% of the total. Reporting peaked in 2022 at $1,672 and has fallen 91.8% since, to $138 in 2025.

$5,041in general payments, 2019–2025

Across 93 payments — averaging $54.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Mentor Worldwide LLC$1K
  • Stryker$359
  • Merz North America, Inc.$329
  • Integra Lifesciences Corporation$301
  • Sanara Medtech Inc.$295
  • plus $407 from 8 others
$6,458in research payments, 2019–2025

Across 5 payments — averaging $1291.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merz North America, Inc.$5K
  • Techmah CMF, LLC$2K

What the payments were for

  • Travel & lodging$4629%
  • Food & beverage$4,57991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,041 in reported general payments places this provider in the 70th percentile of 77 plastic and reconstructive surgery providers in Tennessee.

See all plastic and reconstructive surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$33,362
Medicare patients
28
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate16$107

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →